Trade ABBV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ABBVIE INC. (ABBV) is trading at US$263.96, down 0.02% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$468.22B. Over the past 52 weeks, ABBV has traded between US$190.75 and US$267.47. On Syfe you can trade ABBV with $0 commission and add it to your watchlist.
| Previous close | US$264.02 |
|---|---|
| Market cap | US$468.22B |
| P/E ratio | 16.79 |
| 52-week range | US$190.75 – US$267.47 |
| Dividend yield | 2.62% |
| Volume | 8M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ABBVIE INC.
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Year: 2012
ABBVIE INC. (ABBV) stock is trading at US$263.96, -0.02% from the previous close of US$264.02.
The market cap for ABBVIE INC. (ABBV) stock is approximately US$468.22B.
The price-to-earnings ratio for ABBVIE INC. (ABBV) is 16.79, based on the latest reported earnings.
The 52-week high for ABBVIE INC. (ABBV) stock is US$267.47.
The 52-week low for ABBVIE INC. (ABBV) stock is US$190.75.
Yes, ABBVIE INC. (ABBV) pays a dividend. The trailing 12-month dividend yield is 2.62%.
Stay on top of ABBV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
